Researchers show liquid biopsies can catch disease progression early in high-risk neuroblastoma


Neuroblastoma is an aggressive pediatric cancer that develops from early nerve cells and accounts for up to 10% of childhood cancer deaths. Survival rates are low—less than 50% of patients with the disease survive, and less than 5% with relapsed disease overcome it.

A live biotherapeutic product reduces lung damage in a neonatal mouse model of chronic lung disease

Previous article

Business Contract: What it is and How to Write It

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations